99mTc-Labeled LyP-1 for SPECT Imaging of Triple Negative Breast Cancer
Triple negative breast cancer (TNBC), the most aggressive breast cancer type, is associated with high mortality and recurrence rates. An active-targeted strategy based on homing peptides is an effective approach to diagnose and treat cancer as it can deliver imaging agents or therapeutic drugs into...
Main Authors: | Ningning Song, Lingzhou Zhao, Meilin Zhu, Jinhua Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-Wiley
2019-01-01
|
Series: | Contrast Media & Molecular Imaging |
Online Access: | http://dx.doi.org/10.1155/2019/9502712 |
Similar Items
-
Recent progress in LyP-1-based strategies for targeted imaging and therapy
by: Ningning Song, et al.
Published: (2019-01-01) -
SPECT/CT imaging of chemotherapy-induced tumor apoptosis using 99mTc-labeled dendrimer-entrapped gold nanoparticles
by: Yan Xing, et al.
Published: (2018-01-01) -
Optimization of SPECT/CT imaging protocols for quantitative and qualitative 99mTc SPECT
by: Dennis Kupitz, et al.
Published: (2021-07-01) -
Radiolabeling and Preliminary Evaluation of 99mTc-Labeled DNA Cube Nanoparticles as Potential Tracers for SPECT Imaging
by: Duan X, et al.
Published: (2021-08-01) -
Role of 99mTc-ECD SPECT in the Management of Children with Craniosynostosis
by: Mayadhar Barik, et al.
Published: (2014-01-01)